SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
June 12, 2002
Date of Report (Date of earliest event reported)
NEOTHERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
| Delaware (State or other Jurisdiction of Incorporation) |
000-28782 (Commission File Number) |
93-0979187 (IRS Employer Identification Number) |
| 157 Technology Drive Irvine, California (Address of principal executive offices) |
92618 (Zip Code) |
(949) 788-6700
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
| Item 5. Other Events | ||||||||
| Item 7. Exhibits | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| Exhibit 99.1 | ||||||||
Item 5. Other Events
On June 17, 2002, NeoTherapeutics, Inc. (the “Company”) announced that Nasdaq has notified it that it is not in compliance with the Nasdaq’s minimum bid price per share ($1.00) requirements for continued listing on the Nasdaq National Market, and that the Company has until September 10, 2002, to regain compliance with these rules.
A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.
Item 7. Exhibits
Exhibits:
99.1 Press release dated June 17, 2002.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NEOTHERAPEUTICS, INC. | ||||
| Date: June 17, 2002 | By: | /s/ Samuel Gulko | ||
|
Name: Title: |
Samuel Gulko Senior Vice President, Finance, Chief Financial Officer, Secretary and Treasurer |
|||
3
EXHIBIT INDEX
Exhibits:
99.1 Press release dated June 17, 2002.